Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities
Net income	$ 59,364,000	$ 8,366,000
Adjustments to reconcile net income to net cash provided by operating activities:
Net discount accretion	(17,601,000)	(5,526,000)
Depreciation and amortization expense	11,622,000	5,793,000
Provision for credit losses - loans	51,000	15,348,000
Recovery of credit losses - unfunded loan commitments	(100,000)	(557,000)
Share-based compensation	3,976,000	7,488,000
Gains on sales of loans originated for sale	(841,000)	(667,000)
Fair value adjustments on loans held for sale	(31,000)	(95,000)
Mortgage loans originated for sale	(40,043,000)	(29,372,000)
Proceeds from sales of loans originated for sale	41,503,000	32,389,000
Net gain on sale of OREO and premises held for sale	(119,000)	0
Net (gain) loss on disposal of premises and equipment	(7,000)	400,000
Deferred income tax expense	6,646,000	38,000
Investment securities gains	(71,000)	(254,000)
Net losses on derivatives	343,000	1,316,000
Gain on derivative terminations	0	0
Income from life insurance	(4,071,000)	(2,569,000)
Decrease (increase) in accrued interest receivable and other assets	7,948,000	(12,583,000)
(Decrease) increase in accrued interest payable and other liabilities	(11,147,000)	6,398,000
Other, net	823,000	686,000
Net cash provided by operating activities	58,245,000	26,599,000
Cash flows from investing activities
Proceeds from sales of AFS securities	41,647,000	162,669,000
Maturities, repayments and calls of AFS securities	60,462,000	57,921,000
Purchases of AFS securities	(147,333,000)	(190,293,000)
Net cash and cash equivalents received from acquisitions	0	45,280,000
Net purchases of restricted investments in bank stocks	(3,879,000)	(7,087,000)
Net increase in loans	(32,764,000)	(28,837,000)
Proceeds from sales of portfolio loans	0	1,727,000
Investment in limited partnerships	(1,285,000)	(6,891,000)
Purchases of bank premises and equipment	(3,611,000)	(463,000)
Proceeds from disposal of OREO and premises held for sale	2,182,000	0
Proceeds from disposal of premises and equipment	18,000	0
Purchases of bank owned life insurance	0	(5,000,000)
Death benefit proceeds from life insurance contracts	864,000	0
Other	(15,000)	(374,000)
Net cash (used in) provided by investing activities	(83,714,000)	28,652,000
Cash flows from financing activities
Net (decrease) increase in deposits	(90,387,000)	145,397,000
Net increase (decrease) in borrowings with original maturities less than 90 days	95,538,000	(18,296,000)
Proceeds from FHLB advances with original maturities greater than 90 days	20,000,000	0
Payments on FHLB advances with original maturities greater than 90 days	(15,000,000)	0
Payments on subordinated notes	(32,500,000)	0
Dividends paid	(15,378,000)	(8,722,000)
Acquisition of treasury stock	(94,000)	0
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting	(2,001,000)	(2,393,000)
Proceeds from issuance of employee stock purchase plan shares	151,000	267,000
Other	412,000	115,000
Net cash (used in) provided by financing activities	(39,259,000)	116,368,000
Net (decrease) increase in cash and cash equivalents	(64,728,000)	171,619,000
Cash and cash equivalents at beginning of period	248,874,000	65,161,000
Cash and cash equivalents at end of period	184,146,000	236,780,000
Cash paid during the period for:
Interest	78,082,000	63,206,000
Income taxes	2,200,000	6,825,000
Supplemental schedule of noncash activities:
Premise and equipment transferred to held for sale	0	1,925,000
Lease liabilities arising from obtaining ROU assets	2,010,000	0
Noncash transactions related to merger:
Assets acquired	0	2,154,283,000
Liabilities assumed	$ 0	$ 2,018,067,000